Activity of pan-FGFR inhibitor rogaratinib and PI3K inhibitor copanlisib in preclinical urothelial bladder cancer models

Jerchel, IS; Lejeune, P; Lampignano, R; Walter, A; Lesche, R; Kamburov, A; Mumberg, D; Ellinghaus, P; Politz, O; Gruenewald, S

CANCER RESEARCH, 2019; 79 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索